Reseachers from WEHI (Melbourne, Australia) have found a new way to predict a subset of patients who are likely to become ...

ENRICHED CTCS AND CTDNA PROVIDES COMPLEMENTARY INFORMATION IN NSCLC PATIENTS TREATED WITH ASTRAZENECA'S OSIMERTINIBThe addition of CTC-DNA analysis to clinical trials could identify patients ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

Police announced last Friday 84-year-old Minnesota man Jon K. Miller was arrested for the murder of 25-year-old Mary K.

The Guildford, England-based liquid biopsy company said the study undertaken by the National & Kapodistrian University of Athens used the Parsortix system to isolate and harvest circulating tumour ...

The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...

Good day and thank you for standing by. Welcome to the Absci Q3 2024 Business Update Conference Call. At this time, all ...

Inc. , a global leader in cell-free DNA and genetic testing, today announced the completion of a study using Signatera from the CALGB (Alliance)/SWOG 80702 randomized, phase III clinical trial. CALGB ...

DMD Systems Recovery, LLC (DMD), a Reuse Firsttm IT Asset Disposition (ITAD) services provider, proudly announces its recognition as a Gartner® Representative Provider in the 2024 Gartner Market Guide ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

AstraZeneca’s Lynparza (olaparib ... polymerase (PARP), part of the specialist DNA damage repair system that cancer cells with BRCA and similar mutations rely on to survive.